Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven P Braithwaite

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
The FEBS Journal|October 7, 2009
LRRK2 in Parkinson's disease: building an understanding of disease etiologySteven P Braithwaite
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|June 5, 2019
Plasma-Based Strategies for Therapeutic Modulation of Brain AgingViktoria Kheifets, Steven P Braithwaite
The FEBS Journal|October 7, 2009
LRRK2 in Parkinson's disease: biochemical functionsVasanti S Anand, Steven P Braithwaite
Future Medicinal Chemistry|June 8, 2011
Phosphoprotein phosphatase 2A: a novel druggable target for Alzheimer's diseaseMichael Voronkov, Steven P Braithwaite, Jeffry B Stock
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2002
Differential roles for NSF and GRIP/ABP in AMPA receptor cyclingSteven P Braithwaite, Houhui Xia, Robert C Malenka
Reviews in the Neurosciences|April 14, 2012
α-Synuclein phosphorylation as a therapeutic target in Parkinson's diseaseSteven P Braithwaite, Jeffry B Stock, M Maral Mouradian
Trends in Neurosciences|June 30, 2006
Synaptic plasticity: one STEP at a timeSteven P Braithwaite, Surojit Paul, Angus C Nairn, et al.
Neurochemistry International|February 21, 2012
Targeting phosphatases as the next generation of disease modifying therapeutics for Parkinson's diseaseSteven P Braithwaite, Michael Voronkov, Jeffry B Stock, et al.
Neuron Glia Biology|March 8, 2006
TNFalpha-induced AMPA-receptor trafficking in CNS neurons; relevance to excitotoxicity?Dmitri Leonoudakis, Steven P Braithwaite, Michael S Beattie, et al.
Progress in Molecular Biology and Translational Science|February 21, 2012
Protein phosphatases and Alzheimer's diseaseSteven P Braithwaite, Jeffry B Stock, Paul J Lombroso, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
The FEBS Journal|October 7, 2009
LRRK2 in Parkinson's disease: building an understanding of disease etiologySteven P Braithwaite
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|June 5, 2019
Plasma-Based Strategies for Therapeutic Modulation of Brain AgingViktoria Kheifets, Steven P Braithwaite
The FEBS Journal|October 7, 2009
LRRK2 in Parkinson's disease: biochemical functionsVasanti S Anand, Steven P Braithwaite
Future Medicinal Chemistry|June 8, 2011
Phosphoprotein phosphatase 2A: a novel druggable target for Alzheimer's diseaseMichael Voronkov, Steven P Braithwaite, Jeffry B Stock
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2002
Differential roles for NSF and GRIP/ABP in AMPA receptor cyclingSteven P Braithwaite, Houhui Xia, Robert C Malenka
Reviews in the Neurosciences|April 14, 2012
α-Synuclein phosphorylation as a therapeutic target in Parkinson's diseaseSteven P Braithwaite, Jeffry B Stock, M Maral Mouradian
Trends in Neurosciences|June 30, 2006
Synaptic plasticity: one STEP at a timeSteven P Braithwaite, Surojit Paul, Angus C Nairn, et al.
Neurochemistry International|February 21, 2012
Targeting phosphatases as the next generation of disease modifying therapeutics for Parkinson's diseaseSteven P Braithwaite, Michael Voronkov, Jeffry B Stock, et al.
Neuron Glia Biology|March 8, 2006
TNFalpha-induced AMPA-receptor trafficking in CNS neurons; relevance to excitotoxicity?Dmitri Leonoudakis, Steven P Braithwaite, Michael S Beattie, et al.
Progress in Molecular Biology and Translational Science|February 21, 2012
Protein phosphatases and Alzheimer's diseaseSteven P Braithwaite, Jeffry B Stock, Paul J Lombroso, et al.
Pageof 3